---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-028348"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2024-07-18T23:59:59+00:00"
generated_at: "2026-05-31T19:41:49.101852+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evofem, Aditxt sign amended merger with $1.8M cash and preferred stock

## Summary
- Aditxt to pay up to $1.8M cash for Evofem common stock, less dissenting shares; preferred stock exchange also specified.
- Aditxt commits to purchase $4M of Evofem Series F-1 Preferred Stock in staged tranches by Sept 30, 2024.
- Merger conditions include shareholder approvals, warrant exchanges, and $150K cap on warrant cash-outs.
- Evofem board unanimously recommends merger; proxy statement to be filed with SEC.

## SEC filing metadata
- accession: 0001493152-24-028348
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2024-07-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315224028348/0001493152-24-028348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315224028348/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-028348
- JSON: https://secwatch.observer/filing/0001493152-24-028348.json
- Plain text: https://secwatch.observer/filing/0001493152-24-028348.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.